UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1983, 1, ISBN 0849357241, Volume 1, 207
Acides phosphoniques | Phosphonic acids | Phosphonates | Effets physiologiques | Metabolism | Physiological effect | Métabolisme | Complementary & Alternative Medicine | Phosphonic acids-Metabolism | Phosphonic acids-Physiological effect | Phosphonates-Physiological effect | Phosphonates-Metabolism
Book
Seminars in nuclear medicine, ISSN 0001-2998, 11/2009, Volume 39, Issue 6, p. 369
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 04/2010, Volume 95, Issue 4, pp. 1555 - 1565
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Atrial Fibrillation - chemically induced | Bone Density Conservation Agents - pharmacokinetics | Esophageal Neoplasms - chemically induced | Bone Density Conservation Agents - adverse effects | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - pharmacokinetics | Osteoporosis - drug therapy | Clinical Trials as Topic | Long-Term Care | Pain - chemically induced | Bone Density Conservation Agents - pharmacology | Jaw Diseases - chemically induced | Fractures, Bone - etiology | Osteoporosis - complications | Kidney Diseases - chemically induced | Diphosphonates - therapeutic use | Osteonecrosis - chemically induced | Diphosphonates - adverse effects | Diphosphonates - pharmacology | Fractures, Bone - prevention & control | Index Medicus | Abridged Index Medicus
Journal Article
Bone (New York, N.Y.), ISSN 8756-3282, 2011, Volume 49, Issue 1, pp. 2 - 19
Orthopedics | Bone resorption | Osteoporosis | Osteoclasts | Hydroxyapatite | Bisphosphonates | Bone metastases | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Diphosphates - metabolism | Animals | Calcification, Physiologic - drug effects | Models, Biological | Diphosphonates - chemistry | Humans | Bone Resorption - drug therapy | Bone Resorption - pathology | Diphosphonates - therapeutic use | Structure-Activity Relationship | Diphosphonates - pharmacology | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10001, pp. 1353 - 1361
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Administration Schedule | Breast Neoplasms - pathology | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Breast Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Breast Neoplasms - drug therapy | Clinical trials | Breast cancer | Drug therapy | Analysis | Adjuvant treatment | Cancer | Menopause | Mortality | Estrogen | Postmenopausal women | Metastasis | Studies | Bones | Health risk assessment | Cancer therapies | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Nature medicine, ISSN 1078-8956, 07/2008, Volume 14, Issue 7, pp. 767 - 772
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Immunohistochemistry | Pravastatin - pharmacology | Prenylation - drug effects | Humans | Enzyme Inhibitors - pharmacology | Bone Density Conservation Agents - therapeutic use | Imidazoles - pharmacology | Bone Density Conservation Agents - pharmacology | Mice, Knockout | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Diphosphonates - therapeutic use | Models, Animal | Farnesyltranstransferase - antagonists & inhibitors | Mice | Aging, Premature - drug therapy | Imidazoles - therapeutic use | Drug Therapy, Combination | Pravastatin - therapeutic use | Diphosphonates - pharmacology | Diphosphonates | Progeria | Aging | Research | Drug therapy | Health aspects | Risk factors | Statins | Medical research | Inhibitor drugs | Rodents | Index Medicus | Prenylation | Enzyme Inhibitors | Biochemistry, Molecular Biology | Pravastatin | Aging, Premature | Farnesyltranstransferase | Life Sciences | Imidazoles | Bone Density Conservation Agents | Hydroxymethylglutaryl-CoA Reductase Inhibitors
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 18, pp. 1714 - 1723
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Osteoporosis. Osteomalacia. Paget disease | Biological and medical sciences | General aspects | Medical sciences | Diseases of the osteoarticular system | Humans | Middle Aged | Male | Osteoporosis - drug therapy | Risk | Osteoporosis - etiology | Spinal Fractures - prevention & control | Aged, 80 and over | Diphosphonates - therapeutic use | Imidazoles - therapeutic use | Testosterone - blood | Diphosphonates - adverse effects | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Imidazoles - adverse effects | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Logistic Models | Imidazoles - pharmacology | Bone Density Conservation Agents - pharmacology | Bone Density - drug effects | Analysis of Variance | Hypogonadism - complications | Aged | Diphosphonates - pharmacology | Drugs | Dose-response relationship (Biochemistry) | Osteoporosis | Men | Zoledronic acid | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Risk factors | Vertebrae | Intravenous administration | Calcium | Clinical trials | Bone turnover | Hypogonadism | Serum levels | Testosterone | Fractures | Vitamin D | Older people | Bone mineral density | Bone density | Supplementation | Index Medicus | Abridged Index Medicus
Journal Article
11/2007, Volume 86, Issue 11, 12
Osteoporosis | Bone metastasis | Osteoclast | Bone remodeling | Half-life | Farnesyl pyrophosphase synthase | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Bone Density Conservation Agents - pharmacokinetics | Humans | Bone Density Conservation Agents - therapeutic use | Bone Neoplasms - secondary | Diphosphonates - pharmacokinetics | Half-Life | Nitrogen | Bone Remodeling - drug effects | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Geranyltranstransferase - antagonists & inhibitors | Multiple Myeloma - drug therapy | Bone and Bones - metabolism | Diphosphonates - chemistry | Diphosphonates - therapeutic use | Female | Hypercalcemia - drug therapy | Molecular Structure | Bone Neoplasms - drug therapy | Diphosphonates - pharmacology | Osteoclasts - drug effects | Bone Density Conservation Agents - chemistry | Index Medicus | Dentistry
Book Review